Time-Dependent Risk of Fidelis Lead Failure

American Journal of Cardiology

Volumn 105, Issue 1, 2010, Pages 95-99

  Faulknier, Brett A ^a   Traub, Darren M ^a   Aktas, Mehmet K ^a   Aguila, Alian ^a   Rosero, Spencer ^a   Daubert, James P ^a   Hall, Burr ^a   Shah, Abrar ^a   Taylor, Sarah ^a   McNitt, Scott ^a   Moss, Arthur J ^a   Zareba, Wojciech ^a   Huang, David T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FRACTURE; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 72049119342     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.08.655     Document Type: Article

References (12)

1. Hauser R., and Hayes D. The increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure. Heart Rhythm 6 (2009) 605-610
2. Farwell D., Green M.S., Lemery R., Gollob M.H., and Birnie D.H. Accelerating risk of Fidelis lead fracture. Heart Rhythm 5 (2008) 1375-1379
3. Krahn A.D., Champagne J., Healey J.S., Cameron D., Simpson C.S., Thibault B., Mangat I., Tung S., Sterns L., Birnie D.H., Exner D.V., Parkash R., Sivakumaran S., Davies T., Coutu B., Crystal E., Wolfe K., Verma A., Stephenson E.A., Sanatani S., Gow R., Connors S., Paredes F.A., and Essebag V. Canadian Heart Rhythm Society Device Advisory Committee: outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory Committee. Heart Rhythm 5 (2008) 639-642
4. Klein J., and Moeschberger M. Survival Analysis (1997), Springer, New York 536
5. Daubert J.P., Zareba W., Cannom D., McNitt S., Rosero S.Z., Wang P., Schuger C., Steinberg J.S., Higgins S.L., Wilber D.J., Klein H., Andrews M.L., Hall W.J., Moss A.J., and MADIT II Investigators. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 51 (2008) 1357-1365
6. Vollmann D., Luthje L., Vonhof S., and Unterberg C. Inappropriate therapy and fatal proarrhythmia by an implantable cardioverter-defibrillator. Heart Rhythm 2 (2005) 307-309
7. Epstein A.E., Kay G.N., Plumb V.J., Dailey S.M., and Anderson P.G. Gross and microscopic pathological changes associated with nonthoracotomy implantable defibrillator leads. Circulation 98 (1998) 1517-1524
8. Kron J., Herre J., Renfroe E.G., Rizo-Patron C., Raitt M., Halperin B., Gold M., Goldner B., Wathen M., Wilkoff B., Olarte A., and Yao Q. Lead and device related complications in the Antiarrhythmic Versus Implantable Defibrillators (AVID) trial. Am Heart J 141 (2001) 92-98
9. Israel C., and Barold S. Electrical storm in patients with an implantable defibrillator: A matter of definition. Ann Noninvasive Electrocardiol 12 (2007) 375-382
10. Exner D.V., Pinski S.L., Wyse D.G., Renfroe E.G., Follmann D., Gold M., Beckman K.J., Coromilas J., Lancaster S., Hallstrom A.P., and AVID Investigators. Electrical storm presages nonsudden death: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Circulation 103 (2001) 2066-2071
11. Huang D.T., and Traub D. Recurrent ventricular arrhythmia storms in the age of implantable cardioverter defibrillator therapy: a comprehensive review. Prog Cardiovasc Dis 51 (2008) 229-236
12. Joglar J.A., Kessler D.J., Welch P.J., Keffer J.H., Jessen M.E., Hamdan M.H., and Page R.L. Effects of repeated electrical defibrillations on cardiac troponin I levels. Am J Cardiol 83 (1999) 270-272